Centers for Disease Control and Prevention, Atlanta, Georgia.
Walter Reed National Military Medical Center; Uniformed Services University, Bethesda, Maryland.
Am J Kidney Dis. 2023 Dec;82(6):706-714. doi: 10.1053/j.ajkd.2023.04.013. Epub 2023 Jul 28.
RATIONALE & OBJECTIVE: Although some evidence exists of increased dementia risk from anemia, it is unclear whether this association persists among adults with CKD. Anemia may be a key marker for dementia among adults with CKD, so we evaluated whether anemia is associated with an increased risk of dementia among adults with CKD.
Retrospective cohort study.
SETTING & PARTICIPANTS: The study included 620,095 veterans aged≥45 years with incident stage 3 CKD (estimated glomerular filtration rate [eGFR]<60mL/min/1.73m) between January 2005 and December 2016 in the US Veterans Health Administration system and followed through December 31, 2018, for incident dementia, kidney failure, or death.
Anemia was assessed based on the average of hemoglobin levels (g/L) during the 2 years before the date of incident CKD and categorized as normal, mild, or moderate/severe anemia (≥12.0, 11.0-11.9,<11.0g/dL, respectively, for women, and≥13.0, 11.0-12.9,<11.0g/dL for men).
Dementia and the composite outcome of kidney failure or death.
Adjusted cause-specific hazard ratios were estimated for each outcome.
At the time of incident CKD, the mean age of the participants was 72 years, 97% were male, and their mean eGFR was 51mL/min per 1.73m. Over a median 4.1 years of follow-up, 92,306 veterans (15%) developed dementia before kidney failure or death. Compared with the veterans with CKD without anemia, the multivariable-adjusted models showed a 16% (95% CI, 14%-17%) significantly higher risk of dementia for those with mild anemia and a 27% (95% CI, 23%-31%) higher risk with moderate/severe anemia. Combined risk of kidney failure or death was higher at 39% (95% CI, 37%-40%) and 115% (95% CI, 112%-119%) for mild and moderate/severe anemia, respectively, compared with no anemia.
Residual confounding from the observational study design. Findings may not be generalizable to the broader US population.
Anemia was significantly associated with an increased risk of dementia among veterans with incident CKD, underscoring the role of anemia as a predictor of dementia risk.
PLAIN-LANGUAGE SUMMARY: Adults with chronic kidney disease (CKD) often have anemia. Prior studies among adults in the general population suggest anemia is a risk factor for dementia, though it is unclear whether this association persists among adults with CKD. In this large study of veterans in the United States, we studied the association between anemia and the risk of 2 important outcomes in this population: (1) dementia and (2) kidney failure or death. We found that anemia was associated with a greater risk of dementia as well as risk of kidney failure or death. The study findings therefore emphasize the role of anemia as a key predictor of dementia risk among adults with CKD.
虽然有一些证据表明贫血与痴呆风险增加有关,但在患有 CKD 的成年人中,这种关联是否持续存在尚不清楚。贫血可能是 CKD 成人痴呆的一个关键标志物,因此我们评估了贫血是否与 CKD 成人痴呆风险增加有关。
回顾性队列研究。
该研究纳入了 2005 年 1 月至 2016 年 12 月期间美国退伍军人事务部系统中年龄≥45 岁且患有 3 期 CKD(估计肾小球滤过率[eGFR]<60mL/min/1.73m)的 620095 名退伍军人,并随访至 2018 年 12 月 31 日,以记录痴呆、肾衰竭或死亡的发生情况。
根据 CKD 发病前 2 年的血红蛋白水平(g/L)评估贫血情况,并分为正常、轻度或中重度贫血(女性分别为≥12.0、11.0-11.9、<11.0g/dL,男性分别为≥13.0、11.0-12.9、<11.0g/dL)。
痴呆和肾衰竭或死亡的复合结局。
为每个结局估计了校正后的特定原因风险比。
在发生 CKD 时,参与者的平均年龄为 72 岁,97%为男性,平均 eGFR 为 51mL/min/1.73m。在中位 4.1 年的随访期间,92306 名退伍军人(15%)在肾衰竭或死亡之前发生了痴呆。与无贫血的 CKD 退伍军人相比,多变量调整模型显示轻度贫血患者痴呆风险增加 16%(95%CI,14%-17%),中重度贫血患者痴呆风险增加 27%(95%CI,23%-31%)。与无贫血相比,轻度和中重度贫血患者的肾衰竭或死亡联合风险分别高 39%(95%CI,37%-40%)和 115%(95%CI,112%-119%)。
观察性研究设计的残余混杂。研究结果可能不适用于更广泛的美国人群。
贫血与 CKD 退伍军人的痴呆风险显著相关,这突显了贫血作为痴呆风险预测因素的作用。
患有慢性肾脏病(CKD)的成年人通常会出现贫血。先前在普通人群中进行的研究表明,贫血是痴呆的一个危险因素,但尚不清楚这种关联是否在患有 CKD 的成年人中持续存在。在这项对美国退伍军人的大型研究中,我们研究了贫血与该人群中两个重要结局之间的关联:(1)痴呆症和(2)肾衰竭或死亡。我们发现贫血与痴呆风险增加以及肾衰竭或死亡风险增加相关。因此,研究结果强调了贫血作为 CKD 成人痴呆风险的关键预测因素的作用。